The IL-33/ST2 Pathway in Cerebral Malaria

Int J Mol Sci. 2022 Nov 3;23(21):13457. doi: 10.3390/ijms232113457.

Abstract

Interleukin-33 (IL-33) is an immunomodulatory cytokine which plays critical roles in tissue function and immune-mediated diseases. IL-33 is abundant within the brain and spinal cord tissues where it acts as a key cytokine to coordinate the exchange between the immune and central nervous system (CNS). In this review, we report the recent advances to our knowledge regarding the role of IL-33 and of its receptor ST2 in cerebral malaria, and in particular, we highlight the pivotal role that IL-33/ST2 signaling pathway could play in brain and cerebrospinal barriers permeability. IL-33 serum levels are significantly higher in children with severe Plasmodium falciparum malaria than children without complications or noninfected children. IL-33 levels are correlated with parasite load and strongly decrease with parasite clearance. We postulate that sequestration of infected erythrocytes or merozoites liberation from schizonts could amplify IL-33 production in endothelial cells, contributing either to malaria pathogenesis or recovery.

Keywords: IL-33; Plasmodium; ST2; astrocytes; blood–brain barrier; central nervous system; cerebral malaria; endothelial; inflammation; red blood cells.

Publication types

  • Review

MeSH terms

  • Child
  • Cytokines
  • Endothelial Cells / metabolism
  • Humans
  • Interleukin-1 Receptor-Like 1 Protein / metabolism
  • Interleukin-33 / metabolism
  • Malaria, Cerebral*
  • Malaria, Falciparum* / parasitology
  • Plasmodium falciparum / metabolism

Substances

  • Interleukin-33
  • Interleukin-1 Receptor-Like 1 Protein
  • Cytokines

Grants and funding

Glineur: C., Leleu, I. and Pied, S. are researchers of the “Centre National de la Recherche Scientifique (CNRS)”. The institutional supports are from CNRS and Institut national de la santé et de la recherche médicale (Inserm).